Screening regimens that combine ultrasound and a blood test for ovarian cancer fail to detect the disease early enough to make important progress, the authors of a new study reported. The combo screening also led to unnecessary surgery, which reinforces the need for a more sensitive and more specific test, said the lead researcher.